Unknown

Dataset Information

Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP).


ABSTRACT:

Background

The absolute and relative importance of smoking to vascular and nonvascular outcomes in people with chronic kidney disease (CKD), as well its relevance to kidney disease progression, is uncertain.

Study design

Observational study.

Setting & participants

9,270 participants with CKD enrolled in SHARP.

Predictor

Baseline smoking status (current, former, and never).

Outcomes

Vascular events, site-specific cancer, ESRD, rate of change in estimated glomerular filtration rate (eGFR), and cause-specific mortality.

Results

At baseline, 1,243 (13%) participants were current smokers (median consumption, 10 cigarettes/day); 3,272 (35%), former smokers; and 4,755 (51%), never smokers. Median follow-up was 4.9 years. Vascular event rates were 36% hig

SUBMITTER: Staplin N 

PROVIDER: S-EPMC4996629 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature